Research graph
References from Effectiveness of Oseltamivir in Hospitalized Children With Laboratory-Confirmed Influenza, 2014-2023. Local targets link to admitted publications; unresolved targets remain external evidence.
Neuraminidase inhibitors for preventing and treating influenza in children.
10.1002/14651858.cd002744.pub3 · 2012 · External reference
Neuraminidase inhibitors for preventing and treating influenza in adults and children.
10.1002/14651858.cd008965.pub4 · 2014 · External reference
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
10.1016/s1473-3099(13)70267-6 · 2014 · External reference
Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.
10.1097/inf.0b013e318232ede9 · 2011 · External reference
Influenza antiviral treatment and length of stay.
10.1542/peds.2021-050417 · 2021 · External reference
Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.
10.1017/s0950268818000663 · 2018 · External reference
Association of early oseltamivir with improved outcomes in hospitalized children with influenza, 2007-2020.
10.1001/jamapediatrics.2022.3261 · 2022 · External reference
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
10.1093/cid/ciy866 · 2019 · External reference
Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement.
10.1542/peds.2024-068507 · 2024 · External reference
Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*.
10.1097/pcc.0b013e318260114e · 2012 · External reference
Early use of anti-influenza medications in hospitalized children with tracheostomy.
10.1542/peds.2018-2608 · 2019 · External reference
Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis.
10.1001/jamainternmed.2023.0699 · 2024 · External reference
Associations of oseltamivir with neuropsychiatric and behavioral adverse events: a systematic review and meta-analysis.
10.18553/jmcp.2025.31.10.1051 · 2025 · External reference
Influenza with and without oseltamivir treatment and neuropsychiatric events among children and adolescents.
10.1001/jamaneurol.2025.1995 · 2025 · External reference
Underutilization of influenza antiviral treatment among children and adolescents at higher risk for influenza-associated complications—United States, 2023-2024.
10.15585/mmwr.mm7345a2 · 2024 · External reference
Antiviral use among children hospitalized with laboratory-confirmed influenza illness: a prospective, multicenter surveillance study.
2024 · External reference
Variability of clinician recommendations for oseltamivir in children hospitalized with influenza.
10.1542/peds.2024-069111 · 2025 · External reference
Respiratory and nonrespiratory diagnoses associated with influenza in hospitalized adults.
10.1001/jamanetworkopen.2020.1323 · 2020 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
10.1371/journal.pmed.0040296 · 2007 · External reference
Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials.
10.1093/cid/cix1040 · 2018 · External reference
Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.
10.1086/656408 · 2010 · External reference
Neuraminidase inhibitors for critically ill children with influenza.
10.1542/peds.2013-2149 · 2013 · External reference
Misclassification of both influenza infection and oseltamivir exposure status in administrative data.
10.1001/jamapediatrics.2023.5731 · 2024 · External reference
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.
10.1136/bmj.b5087 · 2010 · External reference
Immortal time bias in pharmaco-epidemiology.
10.1093/aje/kwm324 · 2008 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
